Latest Insider Transactions at Resmed Inc (RSMDF)
This section provides a real-time view of insider transactions for Resmed Inc (RSMDF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RESMED INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RESMED INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2021
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+16.08%
|
-
|
|
Nov 18
2021
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+13.39%
|
-
|
|
Nov 18
2021
|
Resmed Inc Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+6.47%
|
-
|
|
Nov 18
2021
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
478
+0.25%
|
-
|
|
Nov 18
2021
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
478
+6.02%
|
-
|
|
Nov 18
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
986
+0.82%
|
-
|
|
Nov 18
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,612
+5.78%
|
-
|
|
Nov 18
2021
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
1,709
+1.07%
|
-
|
|
Nov 18
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
697
+5.87%
|
-
|
|
Nov 18
2021
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
638
+1.25%
|
-
|
|
Nov 18
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,161
+1.08%
|
-
|
|
Nov 18
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,469
+0.98%
|
-
|
|
Nov 17
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,655
-7.56%
|
$2,452,370
$254.81 P/Share
|
|
Nov 17
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
27,135
-40.45%
|
$6,892,290
$254.81 P/Share
|
|
Nov 17
2021
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
12,060
-13.48%
|
$3,063,240
$254.81 P/Share
|
|
Nov 17
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,112
-32.8%
|
$1,298,448
$254.81 P/Share
|
|
Nov 17
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,210
-8.66%
|
$10,721,340
$254.81 P/Share
|
|
Nov 16
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+11.93%
|
$4,395,978
$254.81 P/Share
|
|
Nov 16
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
45,811
+40.58%
|
$11,635,994
$254.81 P/Share
|
|
Nov 16
2021
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
20,360
+18.54%
|
$5,171,440
$254.81 P/Share
|
|
Nov 16
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
9,162
+37.02%
|
$2,327,148
$254.81 P/Share
|
|
Nov 16
2021
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,162
+15.52%
|
$2,327,148
$254.81 P/Share
|
|
Nov 16
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,360
+16.22%
|
$5,171,440
$254.81 P/Share
|
|
Nov 16
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,262
+12.76%
|
$18,100,548
$254.81 P/Share
|
|
Nov 15
2021
|
Carol Burt Director |
SELL
Open market or private sale
|
Direct |
1,187
-100.0%
|
$320,490
$270.8 P/Share
|
|
Nov 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-27.34%
|
$2,168,000
$271.75 P/Share
|
|
Nov 15
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+21.47%
|
$464,000
$58.24 P/Share
|
|
Nov 11
2021
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,748
-2.06%
|
$2,265,732
$259.47 P/Share
|
|
Nov 11
2021
|
Jan De Witte Director |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-2.51%
|
$26,936
$259.47 P/Share
|
|
Nov 11
2021
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-0.18%
|
$88,578
$259.47 P/Share
|
|
Nov 11
2021
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
976
-13.19%
|
$252,784
$259.47 P/Share
|
|
Nov 11
2021
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
4,100
-5.6%
|
$1,061,900
$259.47 P/Share
|
|
Nov 11
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Bona fide gift
|
Direct |
10,000
-8.3%
|
-
|
|
Nov 11
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
983
+0.81%
|
$99,283
$101.64 P/Share
|
|
Nov 11
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,549
-1.28%
|
$401,191
$259.47 P/Share
|
|
Nov 11
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
945
-4.25%
|
$244,755
$259.47 P/Share
|
|
Nov 10
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.86%
|
$650,000
$260.58 P/Share
|
|
Nov 10
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.78%
|
$142,500
$57.76 P/Share
|
|
Nov 03
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,485
-1.21%
|
$392,040
$264.29 P/Share
|
|
Nov 01
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-3.18%
|
$633,600
$264.35 P/Share
|
|
Oct 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-26.53%
|
$2,040,000
$255.77 P/Share
|
|
Oct 15
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+20.97%
|
$464,000
$58.24 P/Share
|
|
Oct 11
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.57%
|
$1,265,000
$253.37 P/Share
|
|
Oct 11
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.71%
|
$142,500
$57.76 P/Share
|
|
Oct 08
2021
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
234
-0.31%
|
$57,564
$246.52 P/Share
|
|
Oct 04
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.2%
|
$386,620
$260.79 P/Share
|
|
Oct 01
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-3.12%
|
$626,400
$261.33 P/Share
|
|
Sep 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-26.53%
|
$2,328,000
$291.83 P/Share
|
|
Sep 15
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+20.97%
|
$464,000
$58.24 P/Share
|
|
Sep 10
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.42%
|
$1,485,000
$297.33 P/Share
|